Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears Symphonix Devices Vibrant Soundbridge:

This article was originally published in Clinica

Executive Summary

The US FDA has approved Symphonix Devices' PMA supplement for its next generation Vibrant Soundbridge semi-implantable hearing device. The system incorporates eight-channel digital signal processing (DSP) technology, which is housed in the external part of the device allowing Vibrant Soundbridge patients to upgrade their existing system. The San Jose, California company licensed the DSP technology from Siemens and will now programme its Vibrant Soundbridge using Siemens' PC-based Connexx fitting software. The device was CE-marked for sale in Europe last year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT069756

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel